Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells

British Journal of Cancer

Volumn 85, Issue 3, 2001, Pages 453-462

  Hammond, L A ^a   Krinks, C H Van ^a   Durham, J ^a   Tomkins, S E ^a   Burnett, R D ^b   Jones, E L ^a   Chandraratna, R A S ^b   Brown, G ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b ALLERGAN INC   (United States)

Author keywords

Apoptosis; Growth inhibition; Prostate cancer; RAR antagonists; Retinoic acid receptors

Indexed keywords

AGN 190299; AGN 194078; AGN 194301; AGN 194310; AGN 194431; AGN 195153; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR ANTAGONIST; RETINOID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOATES; BENZOIC ACIDS; CELL CYCLE; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOIDS; THIOPHENES; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0035800452     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1939     Document Type: Article

References (36)

1. Retinoids: Biological function and use in the treatment of dermatological diseases
2. Induction of differentiation of the human promyelocytic leukaemia cell line (HL-60) by retinoic acid
3. 3
4. The retinoid signalling pathways: Molecular and genetic analyses
5. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
6. Tazarotene - First of a new generation of receptor-selective retinoids
7. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells
8. Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist
9. Activation of Rb and decline in androgen receptor protein precede retinoic acid induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative
10. Induction of DNA strand breaks associated with apoptosis during treatment of leukaemias
11. Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: Correlation with proliferative activity and tumour grade
12. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion
13. Effects of fenretinide (4-HPR) onprostate LNCaP cell growth, apoptosis and prostate-specific gene expression
14. Synthesis and biological activity of high-affinity retinoic acid receptor antagonists
15. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor-II receptor and lysosomal enzymes
16. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid
17. Recruitment of nuclear corepressor and coactivator to the retinoic acid receptor by retinoid ligands
18. Cancer statistics
19. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3
20. Function of retinoic acid receptor γ in the mouse
21. Differential expression of nuclear retinoid receptors in normal and malignant prostates
22. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo
23. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type
24. High postnatal lethality and testis degeneration in retinoic acid alpha mutant mice
25. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
26. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α
27. Culture of prostatic epithelial cells from ultrasound-guided needle biopsies
28. Retinoid-induced apoptosis and Spl cleavage occur independently of transcription and require caspase activation
29. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide
30. Inhibition of the growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
31. Changing trends
32. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells
33. 3 receptors and actions in human prostate cancer cell lines
34. Identification of highly potent retinoic acid receptor α-selective antagonists
35. Growth of single HL60 cells in liquid culture: Analysis of the influences of differentiative agents
36. Vitamin D derivatives inhibit the mitogenic effects of IGF-1 on MCF-7 human breast cancer cells